4:38 AM
 | 
Jan 08, 2018
 |  BC Extra  |  Company News

ProQR, Galapagos in oligonucleotide deal for fibrosis

ProQR Therapeutics N.V. (NASDAQ:PRQR) and Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG) partnered to discover Axiomer Editing Oligonucleotides (EONs) against Galapagos' fibrosis targets using ProQR's Axiomer RNA technology. Deal...

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >